Published in J Immunol on September 15, 2001
Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun (2003) 1.43
Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect Immun (2004) 1.42
Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog (2009) 1.24
Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation. Infect Immun (2003) 1.13
Evolving models of Lyme disease spirochete gene regulation. Wien Klin Wochenschr (2006) 1.02
Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol (2002) 0.97
Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity. Infect Immun (2006) 0.90
Functional properties of Borrelia burgdorferi recA. J Bacteriol (2004) 0.87
vls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework Heterogeneity. Microbiol Spectr (2014) 0.84
Toll-like receptors 1 and 2 heterodimers alter Borrelia burgdorferi gene expression in mice and ticks. J Infect Dis (2009) 0.80
Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease. J Immunol (2015) 0.77
Passage through Ixodes scapularis ticks enhances the virulence of a weakly pathogenic isolate of Borrelia burgdorferi. Infect Immun (2009) 0.77
Seasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosis. Int J Health Geogr (2002) 0.76
Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi. Front Immunol (2017) 0.75
Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia. Int J Health Geogr (2002) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Lyme disease. N Engl J Med (1989) 14.06
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A (1995) 9.93
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun (1988) 6.64
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A (2000) 4.81
Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun (1995) 4.68
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Infect Immun (1992) 4.42
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science (1992) 3.71
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun (2001) 3.31
Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi. Microb Pathog (1990) 3.24
Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun (1995) 2.96
Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun (1995) 2.86
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol (1998) 2.68
Borrelia burgdorferi erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun (1998) 2.67
Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest (2000) 2.56
Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun (1998) 2.56
Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science (1991) 2.37
Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med (1991) 2.29
Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect Immun (1997) 2.19
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest (1997) 2.05
Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol (1995) 1.96
Bacterial perturbation of cytokine networks. Infect Immun (1998) 1.96
T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med (1995) 1.95
Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg (1990) 1.77
Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis (1994) 1.76
Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids. Infect Immun (2000) 1.71
Serum-mediated resolution of Lyme arthritis in mice. Lab Invest (1996) 1.68
Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol (2000) 1.63
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med (1994) 1.41
Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Cell (1995) 1.38
Genetic and immunological analyses of Vls (VMP-like sequences) of Borrelia burgdorferi. Microb Pathog (1998) 1.32
T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol (1995) 1.26
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J Immunol (1996) 1.25
Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol (2000) 1.23
T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum (1997) 1.23
Fibronectin-binding activity in Borrelia burgdorferi1. Biochim Biophys Acta (1998) 1.17
Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect Immun (1996) 1.12
Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi. Infect Immun (2000) 1.10
Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol (1997) 1.09
Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect Immun (1991) 1.03
C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi. Infect Immun (2001) 1.02
Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J Bacteriol (2000) 1.02
Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun (2000) 1.01
Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J Infect Dis (1993) 1.00
Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Infect Immun (2001) 0.99
Cytokines in murine lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain. J Infect Dis (1998) 0.94
Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium. Can J Microbiol (1991) 0.85
Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur J Immunol (1996) 0.84
Antigenic variation of surface proteins of Borrelia species. Rev Infect Dis (1988) 0.83
Identification of cytokines which enhance (CSF-1, IL-3) or restrict (IFN-gamma) growth of intramacrophage Listeria monocytogenes. Immunol Lett (1991) 0.81
Schistosoma mansoni: effect of recombinant tumor necrosis factor alpha on fecundity and [14C]-tyrosine uptake in females maintained in vitro. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1996) 0.81
Lyme disease. Curr Opin Rheumatol (1995) 0.78
Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (1990) 7.33
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med (1998) 6.18
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
Antibody-coated bacteria in the urine and the site of urinary-tract infection. N Engl J Med (1974) 4.77
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med (1997) 4.06
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun (1994) 3.59
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun (1992) 3.04
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg (1995) 3.04
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A (1992) 2.99
Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect Immun (1995) 2.86
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol (1991) 2.61
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57
Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest (2000) 2.56
Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity (2000) 2.54
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun (1994) 2.42
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 2.38
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis (1991) 2.37
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Transmissible murine colonic hyperplasia. Vet Pathol (1978) 2.11
The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol (1979) 2.11
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis (1994) 2.09
Percutaneous nephrostomy by direct puncture technique: An observational study. Indian J Nephrol (2010) 2.07
Colonoscopic study of 50 patients with colonic tuberculosis. Gut (1992) 2.06
Arthropod- and host-specific gene expression by Borrelia burgdorferi. J Clin Invest (1997) 2.05
The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci (1976) 1.98
Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut (2006) 1.97
Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol (1990) 1.96
Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks. Infect Immun (1999) 1.96
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun (1998) 1.92
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl Acad Sci U S A (1993) 1.84
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun (1998) 1.80
The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79
Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg (1990) 1.77
The rectus sheath block in paediatric anaesthesia: new indications for an old technique? Paediatr Anaesth (1996) 1.76
Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol (2000) 1.76
Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun (1992) 1.75
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74
Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol (2000) 1.63
Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol (1990) 1.63
Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis. J Clin Microbiol (1996) 1.62
Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol (2001) 1.60
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60
Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci (1977) 1.60
Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg (1990) 1.59
Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. J Immunol (2001) 1.58
Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. Infect Immun (1994) 1.57
Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol (2000) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Human granulocytic ehrlichiosis in western Europe. N Engl J Med (1999) 1.55
Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J Clin Microbiol (2000) 1.53
Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene (2001) 1.53
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun (1997) 1.51
Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci (1998) 1.51
Fitness within sport. Br J Sports Med (1977) 1.50
Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis (1994) 1.50
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J Infect Dis (2001) 1.45
A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun (1993) 1.43
Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell depleted stem cell grafts for severe aplasia. Cytotherapy (2004) 1.42
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis. Antimicrob Agents Chemother (1991) 1.41
Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am J Trop Med Hyg (1998) 1.40
Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res (1977) 1.40
Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J Infect Dis (1991) 1.40
The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis (2000) 1.39
OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun (1993) 1.39
OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks. Infect Immun (1997) 1.38
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Detergent solubility of the inositol trisphosphate receptor in rat brain membranes. Evidence for association of the receptor with ankyrin. J Biol Chem (1993) 1.37
Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect Immun (2000) 1.36
Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A (1991) 1.36
Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun (2001) 1.36
Resistance of bacterial biofilms to disinfectants: a review. Biofouling (2011) 1.34
Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Connecticut. J Wildl Dis (1999) 1.32
The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J Clin Invest (1998) 1.31